| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |